Sentences and paragraphs of BRO's Risk Factors and MD&A, 10-K 2026-02-12 against 10-K 2025-02-13.
Each links to the text at sec.gov.
Show the other 60
AddedRisk Factors
•our ability to maintain, develop and deepen relationships with employees, including key brokers, and customers associated with Accession;
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedRisk Factors
•other purchase accounting adjustments that we may record in our financial statements in connection with the Transaction;
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedRisk Factors
•acquisition and integration costs, including restructuring charges and transaction costs;
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedRisk Factors
•the impact of the financing of the Transaction on our operating results or financial condition; and
Read it in 10-K 2026-02-12 at sec.gov ↗
RemovedRisk Factors
those relating to data protection. If any of these risks materialize, such information could become part of a dataset that is accessible by other third-party AI or RPA applications and/or users.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedRisk Factors
disasters is limited and is subject to deductibles and coverage limits. Such coverage may not be adequate or may not continue to be available at commercially reasonable rates and terms.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedRisk Factors
FUTURE PANDEMICS, EPIDEMICS OR OUTBREAKS OF INFECTIOUS DISEASE, AND THE RESULTING GOVERNMENTAL AND SOCIETAL RESPONSES MAY MATERIALLY AND ADVERSELY AFFECT OUR BUSINESS, LIQUIDITY, CUSTOMERS, INSURANCE CARRIERS AND THIRD PARTIES.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedRisk Factors
The COVID-19 pandemic created significant volatility, uncertainty and economic disruption, which could further adversely affect our business and may materially and adversely affect our financial condition, results of operations and cash flows.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedRisk Factors
We cannot predict the impact that future pandemics, epidemics or outbreaks of infectious disease, will have in the future on our customers, insurance carriers, suppliers and other third-party contractors, and each of their financial conditions; however, any material effect on these parties could adversely impact us. Even after a pandemic, epidemic or outbreak of infectious disease has subsided, we may experience materially adverse impacts to our business as a result of the global economic impact of these events. Further, these events may affect our operating and financial results in a manner that is not presently known to us or that we currently do not consider as presenting significant risks to our operations.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedRisk Factors
These and other disruptions related to pandemics, epidemics or outbreaks of infectious disease could materially and adversely affect our business, financial condition, results of operations and cash flows. Further, the potential effects pandemics, epidemics or outbreaks of infectious disease also could impact and, in some cases, magnify many of our risk factors described in this Annual Report on Form 10-K. Additionally, any potential effects of pandemics, epidemics or outbreaks of infectious disease may lag behind the developments related to such events.
Read it in 10-K 2025-02-13 at sec.gov ↗
RewordedRisk Factors
Acquisitions also involve a number of risks, such as diversion of management’s attention; difficulties in the integration of acquired operations and retention of employees; increase in expenses and working capital requirements, which could reduce our return on invested capital; entry into unfamiliar markets or lines of business; unanticipated problems or legal liabilities; estimation of acquisition earn-outs; and tax and accounting issues, some or all of which could have a material adverse effect on our results of operations, financial condition and cash flows.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedRisk Factors
Cybersecurity breaches of any of the systems we rely on may result from circumvention of security systems, denial-of-service attacks or other cyber-attacks, software bugs, malicious or destructive code, hacking, social engineering attacks (including “phishing” attacks attacks, business email compromise and digital or telephonic impersonation), computer viruses, ransomware, malware, employee or insider error or threats, malfeasance, social engineering, physical breaches or other actions, any of which could expose us to unauthorized access, exfiltration, manipulation, corruption, loss or disclosure of proprietary, customer, employee or other data, the inability to render services due to system outages or other business disruptions, regulatory action and scrutiny, monetary and reputational damages and significant increases in compliance costs.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedRisk Factors
Additional post-acquisition risks include integration into our existing culture, managing such acquired business or the larger company that results from such acquisition, an inability to establish uniform standards, controls, systems, procedures and policies, risks related to retention of personnel, entry into unfamiliar or complex markets or lines of business, contingencies or liabilities, liabilities not covered by or in excess of escrowed or indemnified amounts, such as those arising from violations of sanctions laws or anti-corruption laws, risk relating to ensuring compliance with licensing and regulatory requirements and tax and accounting issues.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedRisk Factors
We have put in place administrative, physical, procedures and technological safeguards designed to protect the security and privacy of this information; however, we cannot guarantee that this information will not be improperly disclosed or accessed. accessed, or that the administrative, physical, procedures and technological safeguards are adequate to ensure that this information is timely disposed of or deleted in a manner compliant with such policies and applicable law or regulation.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedRisk Factors
We have internal policies and controls governing the development, procurement, deployment, and use of AI and RPA by our employees designed to align with globally recognized AI principles, maintain trust with customers and protect us from cybersecurity threats, breaches of data privacy, privacy and intellectual property, errors and omissions liability and regulatory enforcement risk; however, our employees could violate these policies and they or external threat actors could circumvent our controls and expose us to such risks.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedRisk Factors
The use We cannot predict the effect of these technologies by our competitors may give them a competitive advantage that cannot be predicted changes at this time, and it they may decrease the demand for our services or negatively affect our assumptions regarding the competitive landscape of our business.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedRisk Factors
We are subject to various actual and potential claims, including the claims detailed in “We are subject to risks related to Accession’s business, including underwriting risk in connection with certain captive insurance companies” above, regulatory actions and other proceedings, including those relating to alleged errors and omissions in connection with the placement or servicing of insurance and/or the provision of services in the ordinary course of business, of which we cannot, and likely will not be able to, predict the outcome with certainty.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedRisk Factors
Many statutory requirements, both in the United States and abroad, include obligations for companies to notify individuals individuals, or the applicable regulatory authority, of security breaches involving certain personal information, information before we fully understand or appreciate the extent of the breach, which could result from breaches experienced by us or our vendors.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedRisk Factors
Significant uncertainty exists as privacy and data protection laws evolve and may be interpreted and applied differently from jurisdiction to jurisdiction may create inconsistent or conflicting requirements. evolve.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedRisk Factors
We are exposed to the risks associated with these inaccuracies, errors and biases, along with the adverse impacts that such flawed models could have on our business and operations.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedRisk Factors
A significant portion of our businesses are concentrated in Florida, Michigan, Massachusetts, California, Massachusetts, Georgia, New York and New York, Georgia where for the year ended December 31, 2024, 2025, we derived approximately 20%, 16%, 9%, 7%, 7%, 8%, 6%, 6%, and 5% of our annual revenue, respectively.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedRisk Factors
Additionally, we use artificial intelligence (“AI”) AI and robotic processing automation (“RPA”) in our business, including with respect to services provided to our customers. business.
Read it in 10-K 2026-02-12 at sec.gov ↗
Quiet changesRisk Factors
In addition, enforcement actions and investigations by regulatory authorities related to data security incidents and privacy violations generally continue to increase.
Read it in 10-K 2026-02-12 at sec.gov ↗
Quiet changesRisk Factors
We will be are subject to the risk that we, our employees and our agents may take actions determined to be in violation of any of these laws, regulations or policies, for which we might be held responsible.
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedMD&A
•“Acquisition/Integration Costs” means the acquisition and integration costs (e.g., costs associated with regulatory filings; costs for third-party professional services, including legal, accounting, consulting, financial advisory and due diligence; costs and fees associated with entry into the bridge financing commitment; costs of integrating or streamlining processes and information technology systems, including data migration and system integration; costs associated with optimizing vendor agreements and leased office space, including exit costs related to location combinations; and employment-related costs, including severance payments, costs associated with the transition of certain legacy compensation programs, retention-related compensation expenses, and incentive payments) arising out of our acquisition of Accession and acquisitions previously completed by Accession, which are not considered to be normal, recurring or part of ongoing operations.
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedMD&A
•“Mark-to-market of escrow liability” is a caption on our consolidated statements of income which reflects the non-cash change in the fair value associated with certain shares of the Company’s common stock held in escrow. The change is driven by fluctuations in our stock price between the beginning of the period and the end of the period. These escrowed shares represent a portion of the merger consideration payable in connection with our acquisition of Accession. The escrowed shares secure certain indemnification obligations of the Accession equity holders related to businesses that are in run-off or discontinued.
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedMD&A
Typically, an income approach is used to estimate the present value of the expected future cash flows associated with the purchased customer accounts. Critical estimates used in the model include forecasting future performance such as projected revenue growth and profit margins, selection of attrition rates and selection of discount rates. To evaluate these assumptions, management considers historical data, operating strategies, expected synergies and available relevant market data. Useful life is estimated as the period over which substantially all of the future cash flows from the purchased customer accounts will be received.
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedMD&A
Many of the acquisitions we complete contain provisions for potential earn-out obligations. The amounts recorded as earn-out payables are based upon the terms of the purchase agreements and the present value of expected future payments to be made to the sellers resulting from estimated future operating results of the acquired entities over a period subsequent to the acquisition date, typically one to three years. The earn-out payables are measured at estimated fair value as of the acquisition date and are included in purchase price consideration. Subsequent changes in the fair value of earn-out obligations are recorded in the Consolidated Statement of Income as a result of updated expectations for the performance of the associated businesses.
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedMD&A
These estimates and assumptions require significant judgment. While management believes the estimates and assumptions are reasonable, they are inherently uncertain. Changes in these estimates and assumptions could affect the carrying value of purchased customer accounts, earnout obligations, and the related future expenses.
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedMD&A
We typically use a combination of market and income approach methodologies to estimate the fair value of our reporting units. The income approach is generally based on a discounted cash flow analysis, which estimates the present value of the projected cash flows to be generated by the reporting unit. Critical estimates and assumptions used in the analysis include forecasting future performance such as projected revenue growth, profit margins and capital expenditures as well as tax rates, cost of capital and risk premiums used in the selection of discount rates. To evaluate these assumptions, management considers historical data, operating strategies and available relevant market data from comparable public companies. The market approach estimates the value of our reporting units by comparing to comparable public companies. Various valuation multiples of companies that are economically and operationally similar are used as data points for selecting multiples for the reporting units. We will from time to time retain the services of certified valuation specialists to assist with the valuation of certain reporting units.
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedMD&A
These estimates and assumptions require significant judgment. While management believes the estimates and assumptions are reasonable, they are inherently uncertain. If our actual results are not consistent with our expectations, we may be required to revise the assessment and, if appropriate, record an impairment charge. That impairment charge could have a material impact on our financial results.
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedMD&A
We completed our most recent evaluation of impairment for goodwill as of November 30, 2025, and determined that the fair value of goodwill exceeded the carrying value for each reporting unit. Additionally, there have been no impairments recorded for amortizable intangible assets for the years ended December 31, 2025, 2024 or 2023.
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedMD&A
Interest expense for 2025 increased $104 million to $297 million, or 53.9%, from 2024. The increase is due to higher debt balances resulting from debt issuance in the second quarter of 2025 to fund the Transaction, which was partially offset by decreases in the floating-rate benchmark used on our adjustable-rate debt.
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedMD&A
The Specialty Distribution Segment is composed of three divisions; our programs business, known as Arrowhead Programs; our wholesale brokerage business, known as Bridge Specialty Group; and our specialty program business, known as Arrowhead Specialty.
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedMD&A
Bridge Specialty Group offers global wholesale brokerage and delegated binding/underwriting capabilities across multiple lines, to independent agents and brokers, including Brown & Brown retail agents. Our teams across the globe provide industry knowledge and expertise, for placements across multiple lines of coverage based on access to admitted, excess and surplus lines carriers, as well as the Lloyd’s markets in the United Kingdom.
Read it in 10-K 2026-02-12 at sec.gov ↗
AddedMD&A
Arrowhead Specialty is composed of our newly acquired specialty businesses from One80 Intermediaries, a segment of Accession, which offer solutions across affinity organizations, administrative services, captives, reinsurance, travel/accident, warranty, and life & health.
Read it in 10-K 2026-02-12 at sec.gov ↗
RemovedMD&A
Beginning January 1, 2024, we no longer exclude Foreign Currency Translation from the calculation of EBITDAC - Adjusted and EBITDAC Margin - Adjusted. Prior periods are presented on the same basis so that the calculations of EBITDAC - Adjusted and EBITDAC Margin - Adjusted are comparable for both periods. We no longer exclude Foreign Currency Translation from the calculation of these earnings measures because fluctuations in Foreign Currency Translation affect both our revenues and expenses, largely offsetting each other. Therefore, excluding Foreign Currency Translation from these earnings measures provides no meaningful incremental value in evaluating our financial performance.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedMD&A
•“Acquisition/Integration Costs” means the acquisition and integration costs (e.g., costs associated with regulatory filings, legal/accounting services, due diligence and the costs of integrating our information technology systems) arising out of our acquisitions of GRP (Jersey) Holdco Limited and its business, Orchid Underwriters Agency and CrossCover Insurance Services, and BdB Limited companies, which are not considered to be normal, recurring or part of the ongoing operations.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedMD&A
•“1Q23 Nonrecurring Cost” means approximately $11.0 million expensed and substantially paid in the first quarter of 2023 to resolve a business matter, which is not considered to be normal, recurring or part of the ongoing operations.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedMD&A
The recorded purchase prices for all acquisitions include an estimation of the fair value of liabilities associated with any potential earn-out provisions, where an earn-out is part of the negotiated transaction. Subsequent changes in the fair value of earn-out obligations are recorded in the Consolidated Statement of Income as a result of updated expectations for the performance of the associated business.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedMD&A
During the first quarter of 2023, the performance conditions for approximately 970,000 shares of the Company’s common stock granted under the Company’s 2019 SIP were determined by the Compensation Committee to have been satisfied relative to the performance-based grants issued in 2020 and 2022. These grants had a performance measurement period that concluded on December 31, 2022. The vesting condition for these grants requires continuous employment for a period of up to five years from the 2020 grant date and four years from the 2022 grant date in order for the awarded shares to become fully vested and nonforfeitable. As a result of the awarding of these shares, the
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedMD&A
During the first quarter of 2024, the performance conditions for approximately 1.2 million shares of the Company’s common stock granted under the Company’s 2019 SIP were determined by the Compensation Committee to have been satisfied relative to the performance-based grants issued in 2021 and 2023. These grants had a performance measurement period that concluded on December 31, 2023. The vesting condition for these grants requires continuous employment for a period of up to five years from the 2021 grant date and four years from the 2023 grant date in order for the awarded shares to become fully vested and nonforfeitable. As a result of the awarding of these shares, the grantees will be eligible to receive payments of dividends and exercise voting privileges. The awarded shares will be included as issued and outstanding common stock shares and included in the calculation of basic and diluted net income per share.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedMD&A
During the first quarter of 2025, the performance conditions for approximately 1 million shares of the Company’s common stock granted under the Company’s 2019 SIP are expected to be determined by the Compensation Committee to have been satisfied relative to the performance-based grants issued in 2022. These grants had a performance measurement period that concluded on December 31, 2024. The vesting condition for these grants requires continuous employment for a period of up to five years from the 2022 grant date in order for the awarded shares to become fully vested and nonforfeitable. As a result of the awarding of these shares, the grantees will be eligible to receive payments of dividends and exercise voting privileges. The awarded shares will be included as issued and outstanding common stock shares and included in the calculation of basic and diluted net income per share.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedMD&A
Other income for 2024 was $7 million, compared with $6 million in 2023. Other income consists of miscellaneous income and therefore, it can fluctuate between comparable periods.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedMD&A
Interest expense for 2024 increased $3 million to $193 million, or 1.6%, from 2023.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedMD&A
potential earn-out obligations are typically based upon future earnings of the acquired operations or entities, usually for periods ranging from one to three years.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedMD&A
On February 10, 2023, the Company entered into Amendment No.1 ("Amendment") of the Second Amended and Restated Credit Agreement, which provided that the overnight London Interbank Offered Rate (“LIBOR”) should be replaced with a successor rate. The amendment also included additional terms and conditions for the Secured Overnight Financing Rate (“SOFR”) loans and Risk-free Reference Rate ("RFR") loans.
Read it in 10-K 2025-02-13 at sec.gov ↗
RemovedMD&A
Payments Due by Period (in millions) Total Less Than 1-3 Years 4-5 Years After 5 1 Year Years Long-term debt $ 3,856 $ 225 $ 781 $ 350 $ 2,500 Other liabilities 241 9 22 19 191 Operating leases(1) 278 54 94 62 68 Interest obligations 1,575 172 287 230 886 Maximum future acquisition contingency payments(2) 494 209 280 5 — Total contractual cash obligations(3),(4) $ 6,444 $ 669 $ 1,464 $ 666 $ 3,645
Read it in 10-K 2025-02-13 at sec.gov ↗
RewordedMD&A
(in millions, except percentages) 2024 2025 % Change 2023 2024 REVENUES Core commissions and fees $ 583 11.3 3,314 23.8 $ 524 2,676 Profit-sharing contingent commissions 27 80.0 15 72 63.6 44 Investment and other income 6 200.0 2 Other income, net — — — 20 122.2 9 Total revenues 616 13.9 541 3,406 24.8 2,729 EXPENSES Employee compensation and benefits 322 13.4 284 1,848 26.4 1,462 Other operating expenses 92 8.2 85 563 25.4 449 (Gain)/loss on disposal — — — 2 (166.7 (3) Amortization 12 9.1 11 219 84.0 119 Depreciation 3 — 3 31 47.6 21 Interest 11 (8.3 12 28 (60.6 71 Change in estimated acquisition earn-out payables 1 (95.0 20 8 — 8 Total expenses 441 6.3 415 2,699 26.9 2,127 Income before income taxes $ 175 38.9 707 17.4 $ 126 602 Income Before Income Taxes Margin (1) 28.4% 23.3% 20.8% 22.1% EBITDAC - Adjusted (2) $ 202 16.8 1,022 24.9 $ 173 818 EBITDAC Margin - Adjusted (2) 32.8% 32.0% 30.0% 30.0% Organic Revenue growth rate (2) 9.1% 12.1% 2.8% 5.8% Employee compensation and benefits relative to total revenues 52.3% 52.5% 54.3% 53.6% Other operating expenses relative to total revenues 14.9% 15.7% Capital expenditures $ 3 0.0 $ 3 Total assets at December 31 $ 1,607 3.1 $ 1,559 16.5% 16.5%
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedMD&A
(in millions, except percentages) 2024 2025 % Change 2023 2024 REVENUES Core commissions and fees $ 2,676 9.1 2,196 17.9 $ 2,453 1,863 Profit-sharing contingent commissions 44 (12.0 50 183 50.0 122 Investment and other income 6 NMF 1 Other income, net 3 (25.0 4 30 (3.2 31 Total revenues 2,729 8.8 2,508 2,409 19.5 2,016 EXPENSES Employee compensation and benefits 1,462 9.4 1,336 919 19.0 772 Other operating expenses 449 6.7 421 458 19.9 382 (Gain)/loss on disposal (3) — (3) (100.0 (28) Amortization 119 6.3 112 93 57.6 59 Depreciation 21 10.5 19 5.6 18 Interest 71 (16.5 85 38 (7.3 41 Change in estimated acquisition earn-out payables 8 17 NMF 1 (6) Total expenses 2,127 7.9 1,971 1,544 24.7 1,238 Income before income taxes $ 602 12.1 865 11.2 $ 537 778 Income Before Income Taxes Margin (1) 22.1% 21.4% 35.9% 38.6% EBITDAC - Adjusted (2) $ 818 7.5 1,038 20.4 $ 761 862 EBITDAC Margin - Adjusted (2) 30.0% 30.3% 43.1% 42.8% Organic Revenue growth rate (2) 5.8% 7.4% 2.8% 17.8% Employee compensation and benefits relative to total revenues 53.6% 53.3% 38.1% 38.3% Other operating expenses relative to total revenues 16.5% 16.8% Capital expenditures $ 48 4.3 $ 46 Total assets at December 31 $ 9,389 8.4 $ 8,658 19.0% 18.9%
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedMD&A
(in millions, except percentages) 2024 2025 % Change 2023 2024 REVENUES Core commissions and fees $5,508 21.3 $4,539 11.6 $4,069 Profit-sharing contingent commissions 255 53.6 166 27.7 130 Investment income 93 78.8 52 Other income, net 7 16.7 6 and other income 139 39.0 100 Total revenues 5,902 22.8 4,805 12.9 4,257 EXPENSES Employee compensation and benefits 2,935 22.0 2,406 10.0 2,187 Other operating expenses 959 35.1 710 9.2 650 Gain (Gain)/loss on disposal 2 (106.5 (31) (78.3 (143) Amortization 312 75.3 178 7.2 166 Depreciation 55 25.0 44 10.0 40 Interest 297 53.9 193 1.6 190 Change in estimated acquisition earn-out payables 25 NMF 2 (90.5 21 Mark-to-market of escrow liability (54) NMF — Total expenses 4,531 29.4 3,502 12.6 3,111 Income before income taxes 1,371 5.2 1,303 13.7 1,146 Income taxes 304 1.0 301 9.5 275 Net income before non-controlling interests 1,067 6.5 1,002 15.0 871 Less:
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedMD&A
(ii) $113 million of Acquisition/Integration Costs that had no comparable costs in the same period of 2024; and (iii) and to a lesser extent, increased variable costs associated with revenue growth, information technology-related costs, partially offset by (iv) the 1Q23 Nonrecurring Cost lower claims costs within our captives and (v) other operating expenses associated with certain third-party claims administration and adjusting services businesses divested in the fourth quarter of 2023 and (vi) the year-over-year decrease of approximately $21 $12 million in the value of assets held to fund the associated liabilities within our deferred compensation plan, which was substantially offset within employee compensation and benefits, as noted above.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedMD&A
The increase includes: includes the issuance of $600 million senior notes, $150 $4,192 million of senior notes net additions to of the Revolving Credit Facility unamortized debt discounts and the amortization of discounted debt related to our various unsecured senior notes and debt issuance cost amortization of $4 million; $8 million, offset by the repayment of $719 million in senior notes and floating-rate debt balances net of Revolving Credit Facility activity and the addition of deferred financing debt issuance costs of $36 million, $225 million of payments on outstanding term loan balances and discount net payments on debt the Revolving Credit Facility of $7 $150 million.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedMD&A
(iii) an increase in non-cash stock-based producer compensation driven by the strong financial performance of the Company associated with revenue growth and (iv) the year-over-year increase of approximately $21 $12 million in the value of deferred compensation liabilities driven by changes in the market prices of our deferred compensation plan, with such amount substantially offset within other operating expenses as we hold assets to fund these liabilities, partially offset by (v) employee compensation and benefits associated with certain third-party claims administration and adjusting services businesses divested in the fourth quarter of 2023. liabilities.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedMD&A
The decrease in EBITDAC Margin - Adjusted was primarily driven by (i) a decrease in profit-sharing contingent commissions, (ii) higher non-cash stock-based compensation and (iii) higher compensation due to investments in employees, which was partially offset by (iv) the net increase in revenue as described above and (v) (ii) leveraging our expense base. base, offset by (iii) the timing of revenues associated with recent acquisitions.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedMD&A
Net income attributable to non-controlling interests 13 44.4 9 NMF — Net income attributable to the Company $1,054 6.1 $993 14.0 $871 Income Before Income Taxes Margin (1) 23.2% 27.1% 26.9% EBITDAC - Adjusted (2) $2,121 25.6 $1,689 17.0 $1,444 EBITDAC Margin - Adjusted (2) 35.9% 35.2% 33.9% Organic Revenue growth rate (2) 2.8% 10.4% 10.3% Employee compensation and benefits relative 49.7% 50.1% 51.4% to total revenues Other operating expenses relative to total revenues 16.2% 14.8% 15.3% Capital expenditures $82 18.8 $69 Total assets at December 31, $17,612 18.3 $14,883
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedMD&A
(i) a decrease in allocated interest expense, (ii) the profit associated with the net increase in revenue as described above and (ii) a decrease in intercompany interest expense, partially offset by, by (iii) the increase in the change in estimated acquisition earn-out payables. increased amortization and depreciation expense; and (iv) Acquisition/Integration Costs.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedMD&A
(ii) $10 approximately $52 million related to core commissions of net new business, renewal business and fees revenue from acquisitions and dispositions that had no comparable revenues in the same period of 2023; fee revenues; and (iii) an increase from the impact of Foreign Currency Translation of $1 $4 million.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedMD&A
Profit-sharing contingent commissions for 2024 in 2025 increased $12 50.0%, or $61 million, from 2024, to $183 million compared to 2023, to $27 million, which was primarily driven by improved underwriting results, favorable loss ratios, increased written premium, finalization of prior-year estimates premiums, and acquisitions completed in the past twelve months.
Read it in 10-K 2026-02-12 at sec.gov ↗
RewordedMD&A
The With respect to performance-based restricted stock awards that become awarded, the grantees are eligible to receive payments of dividends and exercise voting privileges from the awarded date, and the awarded shares will be are included as issued and outstanding common stock shares and included in the calculation of basic and diluted net income per share.
Read it in 10-K 2026-02-12 at sec.gov ↗